AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vaxcyte, Inc. Director's Dealing 2022

Sep 7, 2022

31100_dirs_2022-09-07_142962a5-2c11-4727-960b-9057dcc31ae6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2022-09-02

Reporting Person: PICKERING GRANT (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-02	Common Stock	F	8910	$26.38	Disposed	663546	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	162830	Indirect
Common Stock	162830	Indirect

Footnotes

F1: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.

F2: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

F3: Shares are held directly by a trust for the benefit of the Reporting Person's son.